Tech Company Financing Transactions

Cylene Pharmaceuticals Funding Round

Cylene Pharmaceuticals closed a $12 million investment round on 9/27/2010. Investors included BioVentures Investors, HBM Healthcare Investments and Lilly Ventures.

Transaction Overview

Company Name
Cylene Pharmaceuticals
Announced On
9/27/2010
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Undisclosed
Investors

BioVentures Investors (Peter Feinstein)

HBM Healthcare Investments (Erich Platzer)

Lilly Ventures (Edward Torres)

Mitsui & Co.

Morningside Group

Novartis BioVenture Fund (Reinhard Ambros)

Sanderling Ventures (Fred Middleton)

Proceeds Purpose
Proceeds from the financing will be used to expand the human clinical trials program for CX-4945, including the Phase I trial in patients with multiple myeloma and a series of randomized Phase II trials.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5820 Nancy Ridge Dr. 200
San Diego, CA 92121
USA
Phone
(858) 875-5100
Website
www.cylenepharma.com
Email Address
[email protected]
Overview
Cylene Pharmaceuticalsdiscovers, develops and commercializessmall molecule drugs that target nucleolus and kill cancer cells.
Profile
Cylene Pharmaceuticals LinkedIn Company Profile
Social Media
Cylene Pharmaceuticals Company Twitter Account
Company News
Cylene Pharmaceuticals News
Facebook
Cylene Pharmaceuticals on Facebook
YouTube
Cylene Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
William Rice
  William Rice LinkedIn Profile  William Rice Twitter Account  William Rice News  William Rice on Facebook
Co-Founder
Daniel Hoff
  Daniel Hoff LinkedIn Profile  Daniel Hoff Twitter Account  Daniel Hoff News  Daniel Hoff on Facebook
VP - Bus. Development
Sean O'Brien
  Sean O'Brien LinkedIn Profile  Sean O'Brien Twitter Account  Sean O'Brien News  Sean O'Brien on Facebook
VP - Regulatory Affairs
John Lim
  John Lim LinkedIn Profile  John Lim Twitter Account  John Lim News  John Lim on Facebook

 

 

Browse more venture capital transactions:

Prev: 9/26/2010: Chegg venture capital transaction
Next: 9/27/2010: OnePIN venture capital transaction

 

Share this article

 

Where The Data Comes From

We record funding rounds that are announced publicly. VC transactions on this site are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.